Sorafenib Shows Promise for Heart-Lung Disease (HealthDay)
HealthDay - TUESDAY, May 20 (HealthDay Facts -- The sarcoma anodyne sorafenib (Nexavar) shows contract on account of a control concerning pulmonary hypertension, according to a University of Chicago Medical Affections interpret.
No comments:
Post a Comment